Linköping University Medical Dissertation No. 1033. Following the mevalonate pathway to bone heal alley.
Skoglund
Björn
B
Department of Clinical and Experimental Medicine, Materials in Medicine, Faculty of Health Sciences, Linköping University, Linköping, Sweden. bjorn.skoglund@ltv.se
D000818:Animals; D001696:Biomechanical Phenomena; D050071:Bone Density Conservation Agents / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D001842:Bone and Bones / Q000187:drug effects / Q000378:metabolism; D020099:Coated Materials, Biocompatible; D004164:Diphosphonates / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D004195:Disease Models, Animal; D005264:Femoral Fractures / Q000188:drug therapy; D017102:Fracture Healing / Q000187:drug effects* / Q000502:physiology*; D050723:Fractures, Bone / Q000188:drug therapy / Q000503:physiopathology; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D000077557:Ibandronic Acid; D007279:Injections, Subcutaneous; D008297:Male; D008798:Mevalonic Acid / Q000378:metabolism*; D051379:Mice; D008807:Mice, Inbred BALB C; D051381:Rats; D017207:Rats, Sprague-Dawley; D019821:Simvastatin / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use
D050071:Bone Density Conservation Agents; D020099:Coated Materials, Biocompatible; D004164:Diphosphonates; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D019821:Simvastatin; D008798:Mevalonic Acid; D000077557:Ibandronic Acid